Indefinite Delivery Contract 36C24424D0069

This federal contract IDV was awarded by the U.S. Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit small disadvantaged business. The contract, valued at up to $3,059,720.83, is an Indefinite Delivery Contract to provide radiopharmaceuticals and related services to the Lebanon VA Medical Center in Pennsylvania. Jubilant Radiopharma will deliver a range of nuclear medicine products, including Gallium 68 Dotatate, iodine I-123, and technetium-99m, to support diagnostic imaging and cancer treatment capabilities for veterans across the VA's nationwide network of medical facilities.

The contract is not set aside and has a performance period from August 1, 2024 to July 31, 2029. It is part of Jubilant Radiopharma's broader portfolio of Indefinite Delivery Vehicles with the VA, including Indefinite Delivery Contracts and Blanket Purchase Agreements valued up to $39.8 million. These IDVs enable the VA to efficiently procure critical radiopharmaceutical supplies across its Veterans Integrated Service Networks. The original solicitation sought non-High Enriched Uranium radiopharmaceutical sources and licensure by the Nuclear Regulatory Commission, as well as the ability to meet strict delivery requirements and perform quality control testing.